Professor of Molecular Biosciences and Welch Chair in Chemistry, The University of Texas at Austin
| Role | Organisation | Sources |
|---|---|---|
| Professor of Molecular Biosciences and Welch Chair in Chemistry | The University of Texas at Austin | Brandon BioCatalyst portfolio, Brandon Capital portfolio |
Stories naming Jason McLellan. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Vaxxas has begun an Australian Phase I trial of its needle-free COVID-19 vaccine patch, built on a University of Texas at Austin candidate; the article also recalls the company's early financings led by OneVentures.
Vaxxas has begun an Australian Phase I trial of its needle-free COVID-19 vaccine patch; the article also recalls the company's founding financing led by OneVentures with Brandon Capital and other co-investors.